Does oxytocin nasal spray help people with diabetes insipidus?
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests if a nasal spray with oxytocin (a natural hormone) can improve emotion recognition and reduce stress-related hormone levels in people with central diabetes insipidus compared to healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult (18 years or older).
- You must have a confirmed diagnosis of central diabetes insipidus (AVP deficiency).
- Your hormone treatment (desmopressin and other replacements if needed) has been stable for at least 3 months.
- You cannot be taking any experimental drugs in the last 30 days.
- You cannot have a current or past psychotic disorder (like schizophrenia).
- You cannot be pregnant or breastfeeding in the last 8 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a nasal spray containing oxytocin can improve sexual well-being in people with a condition called arginine vasopressin deficiency (a problem with a hormone that controls water balance). Healthy volunteers who have mild sexual issues will also take part for comparison. Participants receive either the oxytocin spray or a placebo and fill out questionnaires about their sex life.
This trial looks at how the body's oxytocin level changes after taking estrogen pills. It includes healthy people and those with a condition called AVP-deficiency (a lack of a hormone that controls water balance). The study aims to understand how estrogen affects oxytocin.
This study measures oxytocin (a natural hormone) levels in children who have pituitary gland problems. Researchers want to understand if children with certain pituitary conditions don't make enough oxytocin, which could help guide future treatments.
This study tests whether a low dose of MDMA, compared to a placebo, changes oxytocin levels in people with a condition called arginine vasopressin deficiency (also known as central diabetes insipidus). The goal is to understand the role of oxytocin in this condition and explore potential treatment insights.
This study tests whether an oxytocin nasal spray affects social behavior and hormones in postmenopausal women. Being postmenopausal may change how the body responds to oxytocin, so this research aims to see if it can help with mood or social connections.
This study looks at how a hormone called oxytocin affects the brain's reward system in women. If you are a healthy woman with a natural menstrual cycle or on birth control pills, you may be able to join and help researchers understand how oxytocin influences emotions and motivation.
Hear when a new Arginine Vasopressin Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.